Sapienza University of Rome
Rome, Rm, 00161, Italy
NCT Number: NCT07404488
Rapid maxillary expansion (RME) is used to correct transverse deficiencies of the maxilla. This randomized controlled trial compares three RME devices in adolescents (age 10-15) with at least 8 mm maxillary transverse deficiency: (1) bone-borne expander supported by two palatal miniscrews, (2) bone-borne expander supported by four palatal miniscrews, and (3) conventional tooth-borne Hyrax expander. Devices were placed using static computer-guided miniscrew insertion (where applicable). All participants received the same activation protocol to reach 8 mm expansion. Cone-beam CT scans were obtained pre-treatment (T0) and at 6 months post-treatment (T1). The trial assesses skeletal, dentoalveolar, periodontal, and nasal/airway outcomes. Enrollment: 36 subjects. Study sites: Sapienza University of Rome.
Looking for future studies?
Notify Me10 year–15 year
All sexes
Interventional
Not applicable
Rome, Rm, 00161, Italy
This is a prospective, randomized, parallel-group clinical trial performed at the Department of Oral and Maxillofacial Sciences, Sapienza University of Rome (Nov 2021 - Sep 2024). Inclusion criteria included age under 16 years, late mixed or permanent dentition, and maxillary transverse deficiency ≥ 8 mm. Exclusion: poor oral hygiene; previous orthodontic treatment; craniofacial syndromes; cleft lip/palate; genetic/congenital diseases. After consent, eligible participants (N=36) were randomized (1:1:1) to: Group A - two-miniscrew bone-borne expander (paramedian screws near 1st-2nd premolar region); Group B - four-miniscrew bone-borne expander (two paramedian + two parapalatine); Group C - Hyrax tooth-borne expander banded to upper first molars. Miniscrews (Benefit system; PSM Medical Solutions) were placed using a CAD-CAM surgical guide planned from CBCT and digital models (Easy Driver). Activation: Hyrax click 10 mm screw; four quarter-turns at insertion then three quarter-turns/day for 12 days (0.20 mm/turn; ~0.6 mm/day) until 8 mm achieved. CBCT scan acquisition: Scanora 3Dx (Soredex). Measurements performed on Simplant v17 on defined landmarks (MaxBas, MaxAlv, MaxAlvPre, Ns, ZigMax, IntermCo, IntermoAp, molar angles, periodontal bone thickness measures, nasopalatine foramen width). Primary outcome: change in maxillary basal width (MaxBas) T0 to T1 measured on CBCT.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two palatal miniscrews with custom bone-borne expansion framework (device transmits forces to palatal bone; no tooth bands).
Four palatal miniscrews with custom bone-borne expansion appliances.
Hyrax-type tooth-borne expander with bands cemented on upper first molars (Hyrax click 10 mm).
Time frame: at 6 months
Measurement method: CBCT (Simplant software) distance between alveolar/basal points (points 5-6 as per Podesser/Garib protocol).
University of Roma La Sapienza
Other
Prospective Randomized Controlled Study Comparing Dentoalveolar, Skeletal, Periodontal and Nasal/Airway Effects of a Two-miniscrew Bone-borne Expander, a Four-miniscrew Bone-borne Expander, and a Conventional Tooth-borne Hyrax Expander in Adolescents.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07667933
Forensic Dentistry, Intraoral Scanner
Budapest, Pest County, Hungary
View Trial DetailsNCT04444154
Orthodontic Appliance
Rennes, France
View Trial DetailsNCT07382011
Malocclusion Class II, Myofunctional Therapy
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07304310
Case-control Study, Debonding
Milan, Italy
View Trial Details